Renal dysfunction does not affect clinical response in multiple myeloma (MM) patients treated with bortezomib-based regimens

被引:1
|
作者
Ailawadhi, Sikander [1 ]
Mashtare, Terry L. [1 ]
Coignet, Marie V. [1 ]
Depaolo, Dawn M. [1 ]
Miller, Kena C. [1 ]
Wilding, Gregory [1 ]
Chanan-Khan, Asher Alban [1 ]
机构
[1] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1477
引用
收藏
页码:442A / 442A
页数:1
相关论文
共 50 条
  • [1] CMV REACTIVATION IN MULTIPLE MYELOMA TREATED WITH BORTEZOMIB-BASED REGIMENS
    Sampath, V. S.
    Yee, A. Tso Ching
    Lee, L. K.
    Fong, S. Z.
    Lim, Y. C.
    Ponnudurai, K.
    Rajendran, J.
    Ong, K. H.
    [J]. HAEMATOLOGICA, 2014, 99 : 752 - 752
  • [2] Treatment of patients with multiple myeloma complicated by renal failure with bortezomib-based regimens
    Roussou, Maria
    Kastritis, Efstathios
    Migkou, Magdalini
    Psimenou, Erasmia
    Grapsa, Irini
    Matsouka, Charis
    Barmparousi, Despina
    Terpos, Evangelos
    Dimopoulos, Meletios Athanasios
    [J]. LEUKEMIA & LYMPHOMA, 2008, 49 (05) : 890 - 895
  • [3] REVERSIBILITY OF RENAL FAILURE IN MULTIPLE MYELOMA PATIENTS TREATED WITH BORTEZOMIB-BASED REGIMENS: A SINGLE CENTRE EXPERIENCE
    Stefanikova, Z.
    Roziakova, L.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 593 - 593
  • [4] Reversibility of Renal Impairment of Multiple Myeloma Patients Treated with Bortezomib-Based Regimens: Identification of Predictive Factors
    Dimopoulos, Meletios A.
    Roussou, Maria
    Kastritis, Efstathios
    Gavriatopoulou, Maria
    Zagouri, Flora
    Migkou, Magdalini
    Matsouka, Charis
    Barmparousi, Despina
    Christoulas, Dimitrios
    Psimenou, Erasmia
    Grapsa, Irini
    Terpos, Evangelos
    [J]. BLOOD, 2008, 112 (11) : 607 - 608
  • [5] Reversibility of Renal Impairment in Patients With Multiple Myeloma Treated With Bortezomib-Based Regimens: Identification of Predictive Factors
    Dimopoulos, Meletios A.
    Roussou, Maria
    Gavriatopoulou, Maria
    Zagouri, Flora
    Migkou, Magdalini
    Matsouka, Charis
    Barbarousi, Despina
    Christoulas, Dimitrios
    Primenou, Erasmia
    Grapsa, Irini
    Terpos, Evangelos
    Kastritis, Efstathios
    [J]. CLINICAL LYMPHOMA & MYELOMA, 2009, 9 (04): : 302 - 306
  • [6] Superior myeloma response with bortezomib-based regimen in multiple myeloma patients with renal impairment
    Bao, Li
    Lu, Jin
    Wang, Shihua
    Huang, Xiaojun
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (03): : 6200 - 6209
  • [7] BORTEZOMIB-BASED REGIMENS AS INDUCTION AND MAINTENANCE TREATMENT IN MULTIPLE MYELOMA (MM) PATIENTS NOT ELIGIBLE FOR AGGRESSIVE THERAPY
    Mazzone, C.
    Gentile, M.
    Vigna, E.
    Lucia, E.
    Lorio, C.
    Morelli, R.
    Bisconte, M. G.
    Gentile, C.
    Morabito, F.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 544 - 544
  • [8] Clinical Outcomes According to Genomic Abnormalities in 566 Newly Diagnosed Multiple Myeloma Patients Treated with Bortezomib-Based Regimens
    Cavo, Michele
    Bringhen, Sara
    Testoni, Nicoletta
    Omede, Paola
    Marzocchi, Giulia
    Ruggeri, Marina
    Durante, Sandra
    Di Raimondo, Francesco
    Rossi, Davide
    Gorgone, Ausilia
    Patriarca, Francesca
    Petrucci, Maria Teresa
    Buttignol, Silvia
    Levi, Anna
    Offidani, Massimo
    Nozzoli, Chiara
    Ria, Roberto
    Olivero, Barbara
    Galli, Monica
    Montefusco, Vittorio
    Callea, Vincenzo
    Falcone, Antonietta
    De Vivo, Antonio
    Boccadoro, Mafio
    Terragna, Carolina
    Palumbo, Antonio
    [J]. BLOOD, 2009, 114 (22) : 741 - 741
  • [9] Lymphocytopenia Is Associated with an Increased Risk of Severe Infections in Patients with Multiple Myeloma Treated with Bortezomib-Based Regimens
    Jung, Sung-Hoon
    Ahn, Jae-Sook
    Kang, Seung-Ji
    Yang, Deok-Hwan
    Kim, Yeo-Kyeoung
    Kim, Hyeoung-Joon
    Lee, Je-Jung
    [J]. BLOOD, 2012, 120 (21)
  • [10] Lymphocytopenia is associated with an increased risk of severe infections in patients with multiple myeloma treated with bortezomib-based regimens
    Sung-Hoon Jung
    Soo-Young Bae
    Jae-Sook Ahn
    Seung-Ji Kang
    Deok-Hwan Yang
    Yeo-Kyeoung Kim
    Hyeoung-Joon Kim
    Je-Jung Lee
    [J]. International Journal of Hematology, 2013, 97 : 382 - 387